Evidence map›Paper›PMID 39540904›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Comparison of clinical performance between late and standard total-body [

Qiaochu Chen, Liang Dong, Lian Xu, Haitao Zhao, Lianghua Li, Gang Huang, Jianjun Liu, Ruohua Chen

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Bladder activity of different PSMA PET radioligands and impact of furosemide.American journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qiaochu Chen *Department of Nuclear Medicine, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
Liang Dong *Department of Urology, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, Shanghai, China.
Lian XuDepartment of Nuclear Medicine, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
Haitao ZhaoDepartment of Nuclear Medicine, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
Lianghua LiDepartment of Nuclear Medicine, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China.
Gang HuangDepartment of Nuclear Medicine, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China. huang2802@163.com.
Jianjun LiuDepartment of Nuclear Medicine, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China. nuclearj@163.com.
Ruohua ChenDepartment of Nuclear Medicine, School of Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, 160 Pujian Road, Shanghai, 200127, China. crh19870405@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeEnhanced lesion detection in prostate cancer is observed with late [

methodsFrom January 2021 to April 2024, 127 patients with biochemical recurrence of prostate cancer post-radical prostatectomy were enrolled to undergo both standard and late LAFOV [

resultsThe image quality of late LAFOV [

conclusionsThe rate of PET positivity of late LAFOV [

Indexed as

Edetic AcidOligopeptidesPositron Emission Tomography Computed TomographyProstatic NeoplasmsWhole Body ImagingAgedGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesPSMA-1111 PET/CTBiochemical Recurrent Prostate CancerLate LAFOV [68 Ga]GaPSMAStandard LAFOV [68 Ga]GaThe rate of PET positivity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.